What is Marten Trans's earnings per share (EPS)?

Marten Trans (MRTN) reported diluted earnings per share of $0.21 for fiscal year 2025. This represents a -36.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Marten Trans Financials

MRTN

FY2025 annual

Revenue $883.7M -8.3% YoY

Net Income $17.4M -35.2% YoY

EPS (Diluted) $0.21 -36.4% YoY

Free Cash Flow Not reported for FY2025

Source SEC Filings (10-K/10-Q) Data as of Jun 30, 2026 Currency USD FYE December

Marten Trans (MRTN) reported $883.7M in revenue for fiscal year 2025, down 8.3% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI MRTN FY2025 2026-05-08

Earnings have compressed sharply, but cash conversion and balance-sheet discipline still define this asset-heavy transport model.

From FY2022 to FY2025, operating margin fell from 11.3% to 2.6%, so the business produced much less profit per dollar of sales. Yet debt-to-equity improved to 0.2x while equity held near $768M, indicating a drop in earning power rather than a balance sheet stretched to protect volume.

In FY2025, operating cash flow was $93.5M against net income of $17.4M, and a similar gap existed in FY2024. That persistent spread, together with depreciation above $100M, points to an equipment-heavy model where accounting profit understates the cash the operation still produces before reinvestment.

Even with revenue down to $883.7M, cash climbed to $43.3M. The current ratio recovered to 1.9x as receivables fell and total liabilities kept declining, suggesting weaker demand actually released working capital instead of absorbing it.

Financial Health Signals

Financial Health Score 39/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Marten Trans's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Marten Trans has an operating margin of 2.6%, meaning the company retains $3 of operating profit per $100 of revenue. This results in a moderate score of 51/100, indicating healthy but not exceptional operating efficiency. This is down from 3.5% the prior year.

Growth

Marten Trans's revenue declined 8.3% year-over-year, from $963.7M to $883.7M. This contraction results in a growth score of 9/100.

Leverage

Marten Trans carries a low D/E ratio of 0.24, meaning only $0.24 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 72/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Marten Trans's current ratio of 1.86 indicates adequate short-term liquidity, earning a score of 54/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Not available for Marten Trans, and counted as zero in the overall score.

Returns

Marten Trans's ROE of 2.3% shows moderate profitability relative to equity, earning a score of 49/100. This is down from 3.5% the prior year.

Altman Z-Score Safe

6.11

Marten Trans scores 6.11, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($1.2B) relative to total liabilities ($182.1M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

4/7

Marten Trans passes 4 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

5.36x

For every $1 of reported earnings, Marten Trans generates $5.36 in operating cash flow ($93.5M OCF vs $17.4M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$883.7M

YoY-8.3%

5Y CAGR+0.2%

10Y CAGR+2.9%

Marten Trans generated $883.7M in revenue in fiscal year 2025. This represents a decrease of 8.3% from the prior year.

EBITDA

$128.3M

YoY-11.4%

5Y CAGR-8.1%

10Y CAGR-0.6%

Marten Trans's EBITDA was $128.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 11.4% from the prior year.

Net Income

$17.4M

YoY-35.2%

5Y CAGR-24.2%

10Y CAGR-6.9%

Marten Trans reported $17.4M in net income in fiscal year 2025. This represents a decrease of 35.2% from the prior year.

EPS (Diluted)

$0.21

YoY-36.4%

5Y CAGR-24.2%

Marten Trans earned $0.21 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 36.4% from the prior year.

Cash & Balance Sheet

Cash & Debt

$43.3M

YoY+150.6%

5Y CAGR-8.1%

10Y CAGR+58.4%

Marten Trans held $43.3M in cash as of fiscal year 2025; long-term debt is not reported for that period.

Dividends Per Share

$0.24

YoY0.0%

5Y CAGR-17.6%

Marten Trans paid $0.24 per share in dividends in fiscal year 2025. That is unchanged from the prior year.

Shares Outstanding

82M

YoY+0.1%

5Y CAGR-0.3%

Marten Trans had 82M shares outstanding in fiscal year 2025. This represents an increase of 0.1% from the prior year.

Free Cash Flow

Not reported for fiscal year 2025.

Margins & Returns

Operating Margin

2.6%

YoY-0.9pp

5Y CAGR-8.1pp

10Y CAGR-6.6pp

Marten Trans's operating margin was 2.6% in fiscal year 2025, reflecting core business profitability. This is down 0.9 percentage points from the prior year.

Net Margin

2.0%

YoY-0.8pp

5Y CAGR-6.0pp

10Y CAGR-3.4pp

Marten Trans's net profit margin was 2.0% in fiscal year 2025, showing the share of revenue converted to profit. This is down 0.8 percentage points from the prior year.

Return on Equity

2.3%

YoY-1.2pp

5Y CAGR-8.9pp

10Y CAGR-6.5pp

Marten Trans's ROE was 2.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 1.2 percentage points from the prior year.

Gross Margin

Not reported for fiscal year 2025.

Capital Allocation

None of these metrics is reported for fiscal year 2025.

MRTN Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

MRTN annual income statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Revenue	$857.6M	$883.7M-8.3%	$963.7M-14.8%	$1.1B-10.5%	$1.3B+29.8%	$973.6M+11.4%	$874.4M+3.7%	$843.3M+7.1%	$787.6M+12.8%	$698.1M+4.0%	$671.1M+0.9%	$665.0M-1.2%	$672.9M+2.1%	$659.2M+3.3%	$638.5M+5.8%	$603.7M
SG&A Expenses	$299.4M	$312.1M-8.7%	$341.7M-9.8%	$378.8M-2.9%	$390.3M+22.8%	$318.0M+5.9%	$300.2M+9.5%	$274.2M+8.8%	$252.0M+11.5%	$226.1M+0.6%	$224.8M+7.3%	$209.5M+14.2%	$183.5M+7.1%	$171.3M+4.9%	$163.2M+10.6%	$147.6M
Operating Income	$15.8M	$22.9M-31.0%	$33.2M-63.1%	$90.1M-37.1%	$143.3M+28.3%	$111.7M+19.8%	$93.2M+21.9%	$76.5M+8.7%	$70.3M+23.7%	$56.9M-2.5%	$58.3M-4.5%	$61.1M+19.7%	$51.0M-1.9%	$52.0M+13.4%	$45.9M+6.6%	$43.0M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$48K+100.0%	$24K
Income Tax	$5.0M	$6.9M-26.4%	$9.4M-60.0%	$23.5M-30.4%	$33.8M+28.6%	$26.3M+10.1%	$23.9M+43.7%	$16.6M+3.8%	$16.0M+147.3%	-$33.8M-243.3%	$23.6M-5.4%	$24.9M+14.2%	$21.8M-1.4%	$22.2M+22.2%	$18.1M+1.0%	$18.0M
Net Income	$12.6M	$17.4M-35.2%	$26.9M-61.7%	$70.4M-36.2%	$110.4M+29.2%	$85.4M+22.9%	$69.5M+13.8%	$61.1M+11.0%	$55.0M-39.1%	$90.3M+169.8%	$33.5M-6.4%	$35.7M+19.8%	$29.8M-1.0%	$30.1M+10.6%	$27.3M+12.3%	$24.3M
EPS (Diluted)	—	$0.21-36.4%	$0.33-61.6%	$0.86-36.3%	$1.35+32.4%	$1.02+21.4%	$0.84+13.5%	$0.74+10.4%	$0.67	$1.65+170.5%	$0.61-4.7%	$0.64	$0.89-1.1%	$0.90+9.8%	$0.82+12.3%	$0.73

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	$223.5M+9.8%	$203.5M-3.1%	$210.1M-4.7%	$220.5M-4.1%	$229.9M+3.0%	$223.2M-3.2%	$230.4M-2.9%	$237.4M
SG&A Expenses	$72.5M+0.6%	$72.1M-4.8%	$75.7M-4.1%	$79.0M+0.5%	$78.6M-0.3%	$78.8M-5.1%	$83.0M-0.5%	$83.4M
Operating Income	$6.9M+334.4%	$1.6M-65.3%	$4.6M+67.3%	$2.7M-71.9%	$9.7M+66.1%	$5.9M-12.9%	$6.7M+57.6%	$4.3M
Income Tax	$2.3M+244.5%	$667K-50.6%	$1.4M+86.3%	$725K-75.7%	$3.0M+59.3%	$1.9M+25.9%	$1.5M+3.5%	$1.4M
Net Income	$5.3M+286.3%	$1.4M-62.6%	$3.7M+66.1%	$2.2M-69.0%	$7.2M+65.8%	$4.3M-23.0%	$5.6M+50.1%	$3.8M
EPS (Diluted)	$0.07+250.0%	$0.02	N/A	$0.03-66.7%	$0.09+80.0%	$0.05	N/A	$0.05

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses.

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

MRTN Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

MRTN annual balance sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Total Assets	$949.8M-2.0%	$968.8M-2.2%	$990.3M+2.6%	$965.7M+10.9%	$870.7M+4.7%	$831.6M+4.4%	$796.6M+5.7%	$753.9M+9.2%	$690.4M+5.6%	$653.7M+3.5%	$631.5M+9.6%	$576.5M+9.6%	$525.8M+7.2%	$490.6M+4.3%	$470.6M
Current Assets	$171.7M+24.0%	$138.5M-29.5%	$196.6M-16.6%	$235.8M+26.2%	$186.9M+6.4%	$175.7M+13.9%	$154.2M-5.7%	$163.5M+40.2%	$116.6M+24.8%	$93.4M-6.6%	$100.0M-6.5%	$107.0M-0.3%	$107.3M+12.4%	$95.5M-6.2%	$101.8M
Cash & Equivalents	$43.3M+150.6%	$17.3M-67.6%	$53.2M-34.0%	$80.6M+41.4%	$57.0M-13.8%	$66.1M+110.2%	$31.5M-44.6%	$56.8M+259.5%	$15.8M+3135.9%	$488K+12.4%	$434K+252.8%	$123K-99.1%	$13.7M+293.0%	$3.5M-83.3%	$20.8M
Accounts Receivable	$85.8M-4.7%	$90.0M-14.7%	$105.5M-12.6%	$120.7M+21.9%	$99.0M+18.7%	$83.4M-8.0%	$90.7M+9.2%	$83.0M+10.9%	$74.9M+8.2%	$69.2M-2.0%	$70.6M-2.3%	$72.3M+2.0%	$70.9M+7.0%	$66.2M+11.5%	$59.4M
Total Liabilities	$182.1M-9.3%	$200.8M-13.8%	$233.0M-11.0%	$261.8M+19.5%	$219.0M+3.6%	$211.3M+6.2%	$199.0M+11.8%	$177.9M+7.9%	$164.9M-23.8%	$216.4M-2.6%	$222.1M+17.8%	$188.5M+13.1%	$166.7M+5.0%	$158.7M+5.6%	$150.2M
Current Liabilities	$92.2M-1.4%	$93.5M-15.2%	$110.2M-11.3%	$124.3M+32.9%	$93.6M+4.2%	$89.8M+17.6%	$76.3M+6.0%	$72.0M+12.0%	$64.3M+5.9%	$60.7M+21.6%	$49.9M+12.0%	$44.5M-16.0%	$53.0M+13.1%	$46.9M+1.1%	$46.4M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$7.9M-79.2%	$37.9M+55.4%	$24.4M	N/A	$2.7M	N/A
Total Equity	$767.6M0.0%	$767.9M+1.4%	$757.4M+7.6%	$703.9M+8.0%	$651.7M+5.1%	$620.3M+3.8%	$597.6M+3.8%	$576.0M+9.6%	$525.5M+20.2%	$437.3M+6.8%	$409.4M+5.5%	$387.9M+8.0%	$359.1M+9.0%	$329.4M+3.5%	$318.2M
Retained Earnings	$712.0M-0.3%	$714.2M+1.0%	$706.8M+7.8%	$655.9M+16.1%	$565.1M+5.7%	$534.4M+3.3%	$517.3M+3.8%	$498.6M+11.2%	$448.5M+23.7%	$362.6M+9.0%	$332.6M+10.8%	$300.2M+9.7%	$273.7M+11.1%	$246.3M+3.6%	$237.9M

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$955.5M+0.9%	$947.2M-0.3%	$949.8M-2.7%	$975.7M-1.6%	$991.8M+0.9%	$983.3M+1.5%	$968.8M-3.1%	$1.0B
Current Assets	$237.9M+21.6%	$195.6M+13.9%	$171.7M-2.4%	$176.0M+13.0%	$155.8M-4.1%	$162.5M+17.3%	$138.5M-18.7%	$170.3M
Cash & Equivalents	$104.0M+49.0%	$69.8M+61.3%	$43.3M-12.5%	$49.5M+41.2%	$35.1M-12.2%	$39.9M+131.1%	$17.3M-59.8%	$43.0M
Accounts Receivable	$92.0M+0.1%	$91.9M+7.1%	$85.8M-6.7%	$92.0M+0.6%	$91.4M-4.0%	$95.3M+5.8%	$90.0M-3.8%	$93.5M
Total Liabilities	$189.5M+3.6%	$183.0M+0.5%	$182.1M-12.2%	$207.5M-6.2%	$221.1M+2.4%	$215.8M+7.5%	$200.8M-14.0%	$233.5M
Current Liabilities	$95.0M+0.8%	$94.3M+2.2%	$92.2M-20.2%	$115.6M-0.9%	$116.7M+6.4%	$109.6M+17.2%	$93.5M-19.9%	$116.7M
Total Equity	$766.0M+0.2%	$764.2M-0.4%	$767.6M-0.1%	$768.2M-0.3%	$770.7M+0.4%	$767.5M-0.1%	$767.9M+0.2%	$766.5M
Retained Earnings	$709.0M+0.1%	$708.5M-0.5%	$712.0M-0.2%	$713.2M-0.4%	$715.9M+0.3%	$713.6M-0.1%	$714.2M+0.1%	$713.4M

Not reported in any period shown, so not listed: Inventory, Goodwill.

MRTN Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

MRTN annual cash flow statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Operating Cash Flow	$84.8M	$93.5M-30.7%	$134.8M-18.0%	$164.4M-25.1%	$219.5M+28.2%	$171.2M-9.7%	$189.6M+21.2%	$156.5M+1.5%	$154.2M+26.5%	$121.9M-8.9%	$133.8M+4.0%	$128.7M+57.0%	$82.0M-8.1%	$89.2M+4.3%	$85.5M-0.8%	$86.2M
Investing Cash Flow	$7.8M	-$42.9M+71.8%	-$152.1M+11.8%	-$172.5M-27.8%	-$135.0M-9.1%	-$123.7M-16.4%	-$106.3M+24.3%	-$140.5M-34.0%	-$104.9M-10.0%	-$95.3M+2.0%	-$97.3M+22.2%	-$125.1M-5.5%	-$118.6M-58.7%	-$74.7M+15.2%	-$88.1M-82.5%	-$48.3M
Financing Cash Flow	-$18.7M	-$19.6M-5.3%	-$18.6M+3.1%	-$19.2M+68.4%	-$60.9M-7.6%	-$56.6M-16.4%	-$48.6M-17.8%	-$41.3M-392.2%	-$8.4M+25.6%	-$11.3M+69.1%	-$36.5M-1012.2%	-$3.3M-114.2%	$23.1M+638.9%	-$4.3M+71.0%	-$14.8M+34.1%	-$22.4M
Dividends Paid	$19.6M	$19.6M+0.1%	$19.5M+0.2%	$19.5M-0.3%	$19.6M-64.3%	$54.7M+4.5%	$52.4M+24.4%	$42.1M+671.0%	$5.5M+25.2%	$4.4M+32.2%	$3.3M0.0%	$3.3M0.0%	$3.3M+17.9%	$2.8M-85.0%	$18.7M+938.9%	$1.8M
Share Buybacks	N/A	N/A	$0	$0-100.0%	$41.8M	$0-100.0%	$597K	$0-100.0%	$3.8M	$0-100.0%	$7.5M-53.6%	$16.2M	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	$27.7M-16.3%	$33.0M+492.1%	$5.6M-69.9%	$18.5M-44.1%	$33.2M-8.5%	$36.2M+52.2%	$23.8M-19.3%	$29.5M
Investing Cash Flow	$10.7M+767.8%	-$1.6M+77.5%	-$7.1M-223.3%	$5.8M+117.5%	-$33.1M-293.6%	-$8.4M+81.3%	-$44.9M+24.2%	-$59.2M
Financing Cash Flow	-$4.2M+14.8%	-$4.9M-6.0%	-$4.7M+4.8%	-$4.9M0.0%	-$4.9M+5.3%	-$5.2M-11.7%	-$4.6M-3.6%	-$4.5M
Dividends Paid	$4.9M+0.1%	$4.9M+0.1%	$4.9M0.0%	$4.9M0.0%	$4.9M0.0%	$4.9M0.0%	$4.9M+0.1%	$4.9M

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow.

MRTN Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

MRTN annual financial ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Operating Margin	2.6%-0.9pp	3.5%-4.5pp	8.0%-3.4pp	11.3%-0.1pp	11.5%+0.8pp	10.7%+1.6pp	9.1%+0.1pp	8.9%+0.8pp	8.2%-0.5pp	8.7%-0.5pp	9.2%+1.6pp	7.6%-0.3pp	7.9%+0.7pp	7.2%+0.1pp	7.1%
Net Margin	2.0%-0.8pp	2.8%-3.4pp	6.2%-2.5pp	8.7%0.0pp	8.8%+0.8pp	8.0%+0.7pp	7.2%+0.3pp	7.0%-5.9pp	12.9%+7.9pp	5.0%-0.4pp	5.4%+1.0pp	4.4%-0.1pp	4.6%+0.3pp	4.3%+0.3pp	4.0%
Return on Equity	2.3%-1.2pp	3.5%-5.8pp	9.3%-6.4pp	15.7%+2.6pp	13.1%+1.9pp	11.2%+1.0pp	10.2%+0.7pp	9.6%-7.6pp	17.2%+9.5pp	7.6%-1.1pp	8.7%+1.0pp	7.7%-0.7pp	8.4%+0.1pp	8.3%+0.6pp	7.6%
Return on Assets	1.8%-0.9pp	2.8%-4.3pp	7.1%-4.3pp	11.4%+1.6pp	9.8%+1.5pp	8.4%+0.7pp	7.7%+0.4pp	7.3%-5.8pp	13.1%+8.0pp	5.1%-0.5pp	5.7%+0.5pp	5.2%-0.5pp	5.7%+0.2pp	5.6%+0.4pp	5.2%
Current Ratio	1.86+0.4x	1.48-0.3x	1.78-0.1x	1.90-0.1x	2.000.0x	1.96-0.1x	2.02-0.3x	2.27+0.5x	1.81+0.3x	1.54-0.5x	2.01-0.4x	2.40+0.4x	2.020.0x	2.04-0.2x	2.19
Debt-to-Equity	0.240.0x	0.260.0x	0.31-0.1x	0.370.0x	0.340.0x	0.340.0x	0.330.0x	0.310.0x	0.31+0.3x	0.02-0.1x	0.090.0x	0.06-0.4x	0.46+0.5x	0.01-0.5x	0.47

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Margin	3.1%+2.3pp	0.8%-1.4pp	2.2%+0.9pp	1.2%-3.0pp	4.2%+1.6pp	2.6%-0.3pp	2.9%+1.1pp	1.8%
Net Margin	2.4%+1.7pp	0.7%-1.1pp	1.8%+0.8pp	1.0%-2.1pp	3.1%+1.2pp	1.9%-0.5pp	2.4%+0.9pp	1.6%
Return on Equity	0.7%+0.5pp	0.2%-0.3pp	0.5%+0.2pp	0.3%-0.6pp	0.9%+0.4pp	0.6%-0.2pp	0.7%+0.2pp	0.5%
Return on Assets	0.6%+0.4pp	0.1%-0.2pp	0.4%+0.2pp	0.2%-0.5pp	0.7%+0.3pp	0.4%-0.1pp	0.6%+0.2pp	0.4%
Current Ratio	2.50+0.4x	2.08+0.2x	1.86+0.3x	1.52+0.2x	1.34-0.1x	1.480.0x	1.480.0x	1.46
Debt-to-Equity	0.250.0x	0.240.0x	0.240.0x	0.270.0x	0.290.0x	0.280.0x	0.260.0x	0.30

Not reported in any period shown, so not listed: Gross Margin, FCF Margin.

Similar Companies

Heartland Expr HTLD

$993.0M

Werner Entprise WERN

$2.3B

Universal Logistics Hldgs Inc ULH

$504.7M

Arcbest Corp ARCB

$3.1B

Covenant Logistics Group Inc CVLG

$893.3M

Where Marten Trans Ranks

Frequently Asked Questions

What is Marten Trans's annual revenue?

Marten Trans (MRTN) reported $883.7M in total revenue for fiscal year 2025. This represents a -8.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Marten Trans's revenue growing?

Marten Trans (MRTN) revenue declined by 8.3% year-over-year, from $963.7M to $883.7M in fiscal year 2025.

Is Marten Trans profitable?

Yes, Marten Trans (MRTN) reported a net income of $17.4M in fiscal year 2025, with a net profit margin of 2.0%.

What is Marten Trans's EBITDA?

Marten Trans (MRTN) had EBITDA of $128.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Marten Trans's operating margin?

Marten Trans (MRTN) had an operating margin of 2.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Marten Trans's net profit margin?

Marten Trans (MRTN) had a net profit margin of 2.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Marten Trans pay dividends?

Yes, Marten Trans (MRTN) paid $0.24 per share in dividends during fiscal year 2025.

What is Marten Trans's return on equity (ROE)?

Marten Trans (MRTN) has a return on equity of 2.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Marten Trans's operating cash flow?

Marten Trans (MRTN) generated $93.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Marten Trans's total assets?

Marten Trans (MRTN) had $949.8M in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does Marten Trans have outstanding?

Marten Trans (MRTN) had 82M shares outstanding as of fiscal year 2025.

What is Marten Trans's current ratio?

Marten Trans (MRTN) had a current ratio of 1.86 as of fiscal year 2025, which is generally considered healthy.

What is Marten Trans's debt-to-equity ratio?

Marten Trans (MRTN) had a debt-to-equity ratio of 0.24 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Marten Trans's return on assets (ROA)?

Marten Trans (MRTN) had a return on assets of 1.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Marten Trans's Altman Z-Score?

Marten Trans (MRTN) has an Altman Z-Score of 6.11, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Marten Trans's Piotroski F-Score?

Marten Trans (MRTN) has a Piotroski F-Score of 4 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Marten Trans's earnings high quality?

Marten Trans (MRTN) has an earnings quality ratio of 5.36x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Marten Trans?

Marten Trans (MRTN) scores 39 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.